These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Prostate-specific antigen doubling time predicts clinical outcome and survival in prostate cancer patients treated with combined radiation and hormone therapy. Lee AK; Levy LB; Cheung R; Kuban D Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):456-62. PubMed ID: 15927415 [TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal stromal tumors (GISTs) on prostate needle biopsy: A clinicopathologic study of 8 cases. Herawi M; Montgomery EA; Epstein JI Am J Surg Pathol; 2006 Nov; 30(11):1389-95. PubMed ID: 17063078 [TBL] [Abstract][Full Text] [Related]
18. [Diagnostic accuracy of prostate needle biopsies in cancer of the prostate]. Mihatsch MJ; Ohnacker H; Torhorst J; Oberholzer M; Spichtin HP; Eichenberger T; Rist M Helv Chir Acta; 1981 Aug; 48(3-4):383-5. PubMed ID: 7287474 [TBL] [Abstract][Full Text] [Related]
19. [Correlation between re-biopsy one year after endocrine therapy and long-term prognosis in localized prostate cancer]. Kameoka H; Katayose K; Kumakawa K; Shiraiwa Y; Uchida H; Takahashi Y; Yazaki J; Yamaguchi O Gan To Kagaku Ryoho; 2005 Jan; 32(1):57-63. PubMed ID: 15675583 [TBL] [Abstract][Full Text] [Related]
20. Morphology and therapeutic strategies for neuroendocrine tumors of the genitourinary tract. Helpap B Cancer; 2002 Oct; 95(7):1415-20. PubMed ID: 12237909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]